How I think about building things
I began my career in corporate banking at Bank of America, where I learned how large systems really run the unglamorous but essential infrastructure that keeps businesses alive.
What drives me are the gaps everyone else seems to accept. In pharma, I kept asking: Why should bringing medicine to market demand massive upfront investment? Why are emerging markets still underserved? Those questions became the foundation for the companies I’m building today.
But here’s what experience has really taught me: breakthrough isn’t about a secret hack or hidden trick. It’s about doing the boring, repeatable things with discipline regulatory filings, compliance systems, supply-chain rigor, that most people avoid because they seem mundane. Get those right, and suddenly, you can change how the world accesses medicine.
And the best insights don’t come from conferences. They come from conversations with customers, regulators, and even patients because they live with the consequences of what we build.
